Zacks Investment Research
02 Mar 2026, 15:56 UTC · 30w ago
Verdict
Headline takes no side. We score LMAT +0.90 across three claims — strongly bullish.
+0.90strongly bullish
More positive than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
LeMaitre Vascular, Inc. (LMAT) has experienced a 'golden cross' technical pattern, with its 50-day moving average crossing above its 200-day moving average.
More positive than 79% of claims this week
Earnings estimates for LMAT have seen four upward revisions and zero downward revisions over the past 60 days.
So whatConsistent positive revisions to consensus estimates generally lead to increased investor confidence and price appreciation.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 67% of claims this week
LMAT currently holds a #2 (Buy) rating on the Zacks Rank.
So whatA high Zacks Rank indicates a positive short-term outlook based on earnings estimates, though it is less impactful than a #1 Strong Buy.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 96% of ticker scores this week
The article reports a 'golden cross' technical pattern, a Zacks Rank #2 (Buy), and upwardly revised earnings estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
−23.7%
Price is moving against the score
$82.59 vs $108.18 close before publication (Feb 27) · not market-adjusted
LMAT chart →
